Skip to main content
Signal8

Kelderman Kim

SEC insider (Form 3/4/5 filer). CIK 0001739054. Director at CONMED Corp (CNMD) and 1 other issuer. 35 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in LARGO, FL.

Companies Kelderman Kim has filed insider reports for

  • CONMED Corp (CNMD): Director
  • BIO-TECHNE Corp (TECH): Director, Officer, Chief Executive Officer
Kelderman Kim profile photo

Kelderman Kim

CIK: 0001739054

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (5.7%)

Position reduction

Option Exercises (M)11 (31.4%)

Derivative conversions

Awards (A)8 (22.9%)

Compensation grants

Other (G, F, J, C, D, …)14 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CONMED Corp logo
CNMD

CONMED Corp

Director
BIO-TECHNE Corp logo
TECH

BIO-TECHNE Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (35 total)

  • CONMED Corp logo
    CNMD

    CONMED Corp

    Sep 8, 2026
    Exercise
    Direct
    500 shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 17, 2026
    Award

    Restricted Stock Units

    Direct
    93.6K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 17, 2026
    Award

    Restricted Stock Units

    Direct
    57.6K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Disposition

    Performance Restricted Stock Units

    Direct
    8.3K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Disposition

    Performance Stock Options (Right to Buy)

    Direct
    22.4K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Disposition

    Performance Restricted Stock Units

    Direct
    8.8K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Exercise
    Direct
    21.5K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Tax Payment
    Direct
    10.8K shares at avg. $72.40$783K
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Aug 15, 2026
    Disposition

    Performance Stock Options (Right to Buy)

    Direct
    24.3K shares-
  • BIO-TECHNE Corp logo
    TECH

    BIO-TECHNE Corp

    Jul 28, 2026
    Tax Payment
    Direct
    28.7K shares at avg. $72.07$2.1M

1-10 of 35